Optimization Framework for Patient-Specific Cardiac Modeling.


Journal

Cardiovascular engineering and technology
ISSN: 1869-4098
Titre abrégé: Cardiovasc Eng Technol
Pays: United States
ID NLM: 101531846

Informations de publication

Date de publication:
12 2019
Historique:
received: 10 04 2019
accepted: 05 08 2019
pubmed: 19 9 2019
medline: 12 5 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

Patient-specific models of the heart can be used to improve the diagnosis of cardiac diseases, but practical application of these models can be impeded by the computational costs and numerical uncertainties of fitting mechanistic models to clinical measurements from individual patients. Reliable and efficient tuning of these models within clinically appropriate error bounds is a requirement for practical deployment in the time-constrained environment of the clinic. We developed an optimization framework to tune parameters of patient-specific mechanistic models using routinely-acquired non-invasive patient data more efficiently than manual methods. We employ a hybrid particle swarm and pattern search optimization algorithm, but the framework can be readily adapted to use other optimization algorithms. We apply the proposed framework to tune full-cycle lumped parameter circulatory models using clinical data. We show that our framework can be easily adapted to optimize cross-species models by tuning the parameters of the same circulation model to four canine subjects. This work will facilitate the use of biomechanics and circulatory cardiac models in both clinical and research environments by ameliorating the tedious process of manually fitting the parameters.

Identifiants

pubmed: 31531820
doi: 10.1007/s13239-019-00428-z
pii: 10.1007/s13239-019-00428-z
pmc: PMC6868335
mid: NIHMS1540186
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

553-567

Subventions

Organisme : NHLBI NIH HHS
ID : U54 HL119893
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131753
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137100
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103426
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL121754
Pays : United States

Références

Europace. 2016 Dec;18(suppl 4):iv121-iv129
pubmed: 28011839
Exp Physiol. 2009 May;94(5):486-95
pubmed: 19139063
J Comput Phys. 2013 Jul 1;244:4-21
pubmed: 23729839
Med Image Anal. 2009 Oct;13(5):773-84
pubmed: 19664952
Eur J Mech A Solids. 2014 Nov;48:38-47
pubmed: 25267880
Biomech Model Mechanobiol. 2013 Aug;12(4):815-31
pubmed: 23064992
MAGMA. 2006 Feb;19(1):41-5
pubmed: 16477435
Med Image Anal. 2013 Feb;17(2):133-46
pubmed: 23153619
ILAR J. 1997;38(1):41-48
pubmed: 11528046
Biomech Model Mechanobiol. 2012 May;11(5):609-30
pubmed: 21796413
Philos Trans A Math Phys Eng Sci. 2009 Sep 13;367(1902):3445-75
pubmed: 19657007
Circulation. 1993 Feb;87(2):464-9
pubmed: 8425293
Interface Focus. 2016 Apr 6;6(2):20150083
pubmed: 27051509
Ann Intern Med. 2015 Feb 3;162(3):192-204
pubmed: 25531400
Eur J Echocardiogr. 2006 Mar;7(2):79-108
pubmed: 16458610
Eur J Echocardiogr. 2006 Aug;7(4):293-7
pubmed: 16046189
Stat Atlases Comput Models Heart. 2015 Jan;8896:63-73
pubmed: 25729778
Blood Press Monit. 2013 Feb;18(1):50-6
pubmed: 23275315
IEEE Trans Biomed Eng. 2010 Feb;57(2):254-66
pubmed: 19770086
Annu Rev Biomed Eng. 2015;17:351-83
pubmed: 26643023
Cardiovasc Eng. 2007 Sep;7(3):97-120
pubmed: 17846886
Math Biosci. 2013 Jan;241(1):56-74
pubmed: 23046704
Biomech Model Mechanobiol. 2016 Dec;15(6):1509-1521
pubmed: 27008196
Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1943-54
pubmed: 15550528
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H403-12
pubmed: 16428349
Prog Biophys Mol Biol. 2008 Jun-Jul;97(2-3):543-61
pubmed: 18417196
Biomech Model Mechanobiol. 2017 Jun;16(3):971-988
pubmed: 28188386
Prog Biophys Mol Biol. 2011 Oct;107(1):147-55
pubmed: 21763714
Am Fam Physician. 2001 May 1;63(9):1789-98
pubmed: 11352291
Prog Biophys Mol Biol. 2014 Aug;115(2-3):198-212
pubmed: 25117497
Ann Biomed Eng. 2017 Mar;45(3):605-618
pubmed: 27605213

Auteurs

Joshua Mineroff (J)

Department of Mechanical Engineering, Iowa State University, Ames, IA, USA.

Andrew D McCulloch (AD)

Bioengineering and Medicine, University of California, San Diego, La Jolla, CA, USA.

David Krummen (D)

Department of Medicine (Cardiology), University of California, San Diego, La Jolla, CA, USA.

Baskar Ganapathysubramanian (B)

Department of Mechanical Engineering, Iowa State University, Ames, IA, USA.

Adarsh Krishnamurthy (A)

Department of Mechanical Engineering, Iowa State University, Ames, IA, USA. adarsh@iastate.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH